Table 1 No changes in blood pressure, heart rate and respiratory rate when hs-MB administration.

From: Delivery of Hydrogen Sulfide by Ultrasound Targeted Microbubble Destruction Attenuates Myocardial Ischemia-reperfusion Injury

 

0 min

5 min

10 min

15 min

20 min

25 min

30 min

35 min

40 min

Systolic blood pressure (mm Hg)

 Control

113 ± 4

111 ± 7

117 ± 3

109 ± 4

113 ± 4

115 ± 4

117 ± 4

116 ± 6

114 ± 4

 hs-MB

113 ± 8

114 ± 3

113 ± 7

113 ± 7

114 ± 8

108 ± 10

111 ± 12

112 ± 7

116 ± 6

 hs-MB + US

110 ± 14

113 ± 7

109 ± 4

114 ± 5

113 ± 7

111 ± 7

107 ± 15

111 ± 14

111 ± 10

Diastolic blood pressure (mm Hg)

 Control

75 ± 8

77 ± 4

78 ± 9

76 ± 4

73 ± 5

74 ± 3

71 ± 4

71 ± 5

70 ± 5

 hs-MB

75 ± 5

70 ± 6

70 ± 5

74 ± 5

70 ± 3

75 ± 7

79 ± 5

71 ± 6

73 ± 4

 hs-MB + US

74 ± 8

70 ± 6

73 ± 6

73 ± 5

75 ± 8

76 ± 11

73 ± 10

76 ± 3

75 ± 6

Heart rate (bpm)

 Control

393 ± 12

389 ± 22

387 ± 18

383 ± 18

386 ± 9

3858 ± 

388 ± 14

384 ± 21

390 ± 23

 hs-MB

381 ± 14

383 ± 7

380 ± 12

389 ± 19

382 ± 18

385 ± 9

395 ± 2

388 ± 14

381 ± 14

 hs-MB + US

387 ± 21

369 ± 11

377 ± 23

387 ± 18

377 ± 25

379 ± 18

379 ± 27

374 ± 16

387 ± 17

Respiratory rate (bpm)

 Control

60 ± 4

61 ± 4

61 ± 3

62 ± 3

60 ± 3

61 ± 2

60 ± 7

59 ± 3

60 ± 7

 hs-MB

58 ± 6

59 ± 4

60 ± 2

63 ± 7

61 ± 6

60 ± 8

60 ± 7

64 ± 3

59 ± 3

 hs-MB + US

63 ± 4

61 ± 6

63 ± 3

63 ± 4

59 ± 4

64 ± 3

62 ± 5

62 ± 9

60 ± 8